Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

202218 citationsJournal Articlegold Open Access

Authors

Anne-Noëlle Frix · Centre Hospitalier Universitaire de Liège

Liam G. Heaney · Queen's University Belfast

Barbro Dahlén · Karolinska Institutet

Florin Mihălţan · Institutul de Pneumoftiziologie "Marius Nasta"

Svetlana Sergejeva · University of Tartu

Sanja Popović‐Grle · University Hospital Centre Zagreb

Vratislav Sedlák

Abstract

Our study reveals important heterogeneity in the use of asthma biologics across Europe. To what extent this impacts on clinical outcomes relevant to patients and healthcare services needs further investigation.

Topics & Keywords

Asthma and respiratory diseases Respiratory and Cough-Related Research Allergic Rhinitis and Sensitization

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: ERJ Open Research

Volume 8, Issue 4, pp. 00273-2022

DOI: 10.1183/23120541.00273-2022

Field-Weighted Citation Impact: 2.01